Results 91 to 100 of about 7,433 (204)

A pulmonary cavitated mass complicating long-standing allergic bronchopulmonary aspergillosis

open access: yes, 2005
A cavitated mass of unknown origin was surgically resected in a 64-year-old lady with a 16 years long history of allergic bronchopulmonary aspergillosis without asthma.
Remmelink, Myriam   +4 more
core   +1 more source

[Allergic bronchopulmonary aspergillosis; an important cause of asthma sometimes ignored].

open access: yes, 1990
The Authors describe a clinical case of allergic bronchopulmonary aspergillosis that remained unrecognized for a long time. The pathogenetic role of the environment, home climatology, and familiarity is considered.
Lanati L   +6 more
core  

Omalizumab Therapy for Allergic Bronchopulmonary Aspergillosis in Children with Cystic Fibrosis: A Synthesis of Published Evidence

open access: yes, 2014
Allergic bronchopulmonary aspergillosis (ABPA) complicating cystic fibrosis (CF) is treated with corticosteroids. Since elevated IgE is a cardinal abnormality, anti-IgE has been used sporadically as adjuvant treatment.
Zintzaras, E., Kaditis, A. G., Tanou, K.
core   +2 more sources

Diagnosis of allergic bronchopulmonary aspergillosis (ABPA) in cystic fibrosis

open access: yes, 2000
The diagnosis of allergic bronchopulmonary aspergillosis (ABPA) in cystic fibrosis (CF) patients may be difficult to establish because ABPA shares many characteristics with coexisting atopy or other lung infections in these patients.
Reimert, C M   +3 more
core  

Allergic Bronchopulmonary Aspergillosis

open access: yesChest, 1987
Patterson, Roy, Greenberger, Paul
openaire   +2 more sources

Intravenous immunoglobulin protects from experimental allergic bronchopulmonary aspergillosis via a sialylation-dependent mechanism.

open access: yes, 2019
Intravenous immunoglobuin (IVIG) exerts protective effects in experimental allergic bronchopulmonary aspergillosis (ABPA) via a sialylation‐dependent mechanism. The protection was associated with reduced recruitment of eosinophils, diminished goblet cell
Bayry J.   +4 more
core   +2 more sources

Allergic bronchopulmonary aspergillosis without asthma complicating pulmonary tuberculosis

open access: yes, 2012
Allergic bronchopulmonary aspergillosis (ABPA) is typically associated with asthma. Presence of asthma is one of the minimal essential diagnostic criteria for ABPA. Rarely, ABPA has been described in association with other diseases without asthma. It has
Mansi Gupta   +2 more
core   +1 more source

Miliary nodules: An unusual presentation of allergic bronchopulmonary aspergillosis

open access: yes, 2014
Allergic bronchopulmonary aspergillosis (ABPA) is an immune-mediated inflammatory disease caused by hypersensitivity to Aspergillus fumigatus. A wide spectrum of plain radiographic appearances has been described in ABPA, though none are pathognomonic of ...
Pooja Aneja   +3 more
core   +1 more source

Allergic bronchopulmonary aspergillosis manifesting as recurrent pneumonia in an adolescent: a case report

open access: yes, 2020
Allergic bronchopulmonary aspergillosis (ABPA) is a pulmonary disorder caused by hypersensi- tivity to Aspergillus fumigatus. The diagnosis is based on sensitization to Aspergillus, associated with clinical, immunological and radiological ...
Arturi, Elisa   +6 more
core  

Interplay of Cytokines and Chemokines in Aspergillosis

open access: yesJournal of Fungi
Aspergillosis is a fungal infection caused by various species of Aspergillus, most notably A. fumigatus. This fungus causes a spectrum of diseases, including allergic bronchopulmonary aspergillosis, aspergilloma, chronic pulmonary aspergillosis, and ...
Jata Shankar   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy